The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice

Anesthesia and Analgesia

Volumn 101, Issue 6, 2005, Pages 1763-1769

  Quintão, Nara L M ^a   Medeiros, Rodrigo ^a   Santos, Adair R S ^a   Campos, Maria M ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; DIACETYLRHEIN; FREUND ADJUVANT; GABAPENTIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; FEMALE; INFLAMMATION; LOCOMOTION; MOTOR COORDINATION; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RECTUM TEMPERATURE; SCIATIC NERVE; STATISTICAL ANALYSIS;

EID: 28344435597     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000184182.03203.61     Document Type: Article

References (26)

1. Leblan D, Chantre P, Fournie B. Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine 2000;67:462-7.
2. Pelletier JP, Yaron M, Haraoui B, et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum 2000;43:2339-48.
3. Smith GNJR, Myers SL, Brandt KD, et al. Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis. Arthritis Rheum 1999;42: 545-54.
4. Moore AR, Greenslade KJ, Alam CA, et al. Effects of diacerhein on granuloma induced cartilage breakdown in the mouse. Osteoarthritis Cartilage 1998;6:19-23.
5. Tamura T, Ohmori K. Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis. Eur J Pharmacol 2001;419:269-74.
6. Pelletier JP, Mineau F, Fernandes JC, et al. Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol 1998;25:2417-24.
7. Skøtt O. Pain. New insights, new treatments? Am J Physiol Regul Integr Comp Physiol 2003;285:R30-1.
8. Calixto JB, Scheldt C, Otuki MF, et al. Biological activity of plants extracts: novel analgesic drug. Expert Opin Emerging Drugs 2001;6:261-79.
9. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
10. Bortolanza LB, Ferreira J, Hess SC, et al. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. Eur J Pharmacol 2002;453:203-8.
11. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 1998;76:215-22.
12. Dunham NW, Miya TS. A note on a simple apparatus for detecting neurobiological deficit in rats and mice. J Am Pharm Assoc 1957;46:208-9.
13. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003;348:1243-55.
14. Guthrie AJ, Short CR, Swan GE, et al. Characterization of a sterile soft-tissue inflammation model in thoroughbred horses. J Vet Pharmacol Ther 1996;19:44-9.
15. Posadas I, Bucci M, Roviezzo F, et al. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol 2004;142:331-8.
16. Bucci M, Roviezzo F, Posadas I, et al. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci U S A 2005;102:904-8.
17. Chan CF, Sun WZ, Lin JK, et al. Activation of transcription factors of nuclear factor kappa B, activator protein-1 and octamer factors in hyperalgesia. Eur J Pharmacol 2000;402:61-8.
18. Dogrul A, Gardell LR, Ossipov MH, et al. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 2003;105:159-68.
19. Cui JG, Holmin S, Mathiesen T, et al. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 2000;88:239-48.
20. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361:184-7.
21. Saleh TS, Calixto JB, Medeiros YS. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 1999;20:949-56.
22. Moldovan F, Pelletier JP, Jolicoeur FC, et al. Diacerhein and rhein reduce the ICE-induced IL-1beta and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000;8: 186-96.
23. Mendes AF, Caramona MM, De Carvalho AP, et al. Role of mitogen-activated protein kinases and tyrosine kinases on interleukine-1β-induced NF-κ B activation and iNOS expression in bovine articular chondrocytes. Nitric Oxide 2002;6:35-44.
24. Tamura T, Shirai T, Kosaka N, et al. Pharmacological studies of diacerhein in animal models of inflammation, arthritis and bone reabsortion. Eur J Pharmacol 2002;448:81-7.
25. Hanesh U, Pawlak M, McDougall JJ. Gabapentin reduces the mechanosensitivity of fine afferent nerve fibres in normal and inflamed rat knee joints. Pain 2003;104:363-6.
26. Gee NS, Brown JP, Dissanayake VU, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996;271:5768-76.